Deepthi Yedlapudi
Postdoctoral Associate (previously held)
Boston University Chobanian & Avedisian School of Medicine
Biochemistry & Cell Biology

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Dinda B, Das B, Biswas S, Sharma H, Armstrong C, Yedlapudi D, Antonio T, Reith M, Dutta AK. Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein. Bioorg Med Chem. 2023 Jan 15; 78:117131. PMID: 36571976; PMCID: PMC9898996; DOI: 10.1016/j.bmc.2022.117131;
  2. Yedlapudi D, Xu L, Luo D, Marsh GB, Todi SV, Dutta AK. Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementia. Sci Rep. 2019 12 23; 9(1):19648. PMID: 31873106; PMCID: PMC6927976; DOI: 10.1038/s41598-019-55830-3;
  3. Islas-Robles A, Yedlapudi D, Lau SS, Monks TJ. Toxicoproteomic Analysis of Poly(ADP-Ribose)-Associated Proteins Induced by Oxidative Stress in Human Proximal Tubule Cells. Toxicol Sci. 2019 Sep 01; 171(1):117-131. PMID: 31165168
  4. Elmabruk A, Das B, Yedlapudi D, Xu L, Antonio T, Reith MEA, Dutta AK. Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson's Disease. ACS Chem Neurosci. 2019 01 16; 10(1):396-411. PMID: 30301349
  5. Vinnakota RL, Yedlapudi D, Manda KM, Bhamidipati K, Bommakanti KT, RangaLakshmi GS, Kalivendi SV. Identification of an Alternatively Spliced a-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis. ACS Chem Neurosci. 2018 12 19; 9(12):2948-2958. PMID: 29996045
  6. Yedlapudi D, Joshi GS, Luo D, Todi SV, Dutta AK. Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model. Sci Rep. 2016 12 05; 6:38510. PMID: 27917933
  7. Luo D, Sharma H, Yedlapudi D, Antonio T, Reith MEA, Dutta AK. Novel multifunctional dopamine D2/D3 receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation properties. Bioorg Med Chem. 2016 11 01; 24(21):5088-5102. PMID: 27591013
  8. Hyder I, Yedlapudi D, Kalivendi SV, Khazir J, Ismail T, Nalla N, Miryala S, Sampath Kumar HM. Synthesis and Biological evaluation of novel 4ß-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds. Bioorg Med Chem Lett. 2015 Jul 15; 25(14):2860-3. PMID: 26022842
  9. Manda KM, Yedlapudi D, Korukonda S, Bojja S, Kalivendi SV. The chaperone-like activity of a-synuclein attenuates aggregation of its alternatively spliced isoform, 112-synuclein in vitro: plausible cross-talk between isoforms in protein aggregation. PLoS One. 2014; 9(6):e98657. PMID: 24892822
  10. Kalivendi SV, Yedlapudi D, Hillard CJ, Kalyanaraman B. Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease. Free Radic Biol Med. 2010 Feb 01; 48(3):377-83. PMID: 19857570

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 2 publications in 2016 and 2018 and 2019


Contact for Mentoring:

Yedlapudi's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department